At Myovant, we believe that significant challenges remain for men with prostate cancer despite recent progress. Prostate cancer is the second most common cancer and the second leading cause of cancer death in men in the U.S. Prostate cancer also has the largest racial disparity of any major cancer, killing Black men twice as often as white men.

Despite new medications and increased public awareness, there remains an inadequate focus on the full spectrum of mental and physical health issues that men with prostate cancer face—especially among men who are Black, men who have sex with men (MSM), and U.S. veterans.

Our approach to transformative advocacy is twofold: we’re funding important projects and partnering with passionate leaders to redefine care for men with prostate cancer.

We’re working across sectors to address the complex set of challenges that these men face, including persistent racial disparities. Through partnership, we can accelerate the momentum to improve the lives of men with prostate cancer.